Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin's Lymphoma
Phase of Trial: Phase II
Latest Information Update: 03 Sep 2018
At a glance
- Drugs Rituximab (Primary) ; Bleomycin; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Apr 2013 Planned end date changed from 1 May 2009 to 1 May 2014 as reported by ClinicalTrials.gov.